tiprankstipranks
pc:alebu

Alebund Pharmaceuticals

Shanghai, Shanghai, China
www.alebund.com
Alebund Pharmaceuticals is an integrated biopharmaceutical company dedicated to developing innovative therapies for renal diseases and related chronic conditions. The company focuses on advancing its pipeline of treatments, including a best-in-class iron-based phosphate binder and a first-in-class pan phosphate transporter inhibitor, while also expanding the commercial reach of its products in China and globally.

Leadership & Board

Key Executives
Co-Founder and Chief Medical OfficerJin Tian
Co-Founder and Chief Executive OfficerGavin Xia
Current Number of Employees14
Current LinkedIn Followers144

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$550M
Total Amount Raised$550M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$550M
Latest Funding Amount$550M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation
Post-Money Valuation

Employee Trend

Alebund Pharmaceuticals had 14 employees as of May 18, 2026. The number of employees increased by 0 (0.00%) week-over-week.
14Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Alebund Pharmaceuticals had 144 followers as of May 18, 2026. The number of followers increased by 5 (3.60%) week-over-week.
144Latest Followers Count
5(3.60%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 07, 2025
Series C
$550.00M

Investors

Related News and Analysis